Figures & data
Table I. Gender, tumour characteristics and previous therapy according to age of patients with advanced colorectal cancer treated with capecitabine or XELOX.
Figure 1. Progression free survival from start of palliative capecitabine or XELOX therapy for advanced colorectal cancer according to age < 70 and ≥70 years.
![Figure 1. Progression free survival from start of palliative capecitabine or XELOX therapy for advanced colorectal cancer according to age < 70 and ≥70 years.](/cms/asset/a85be78e-35bd-4866-a2e9-a59844681917/ionc_a_137504_f0001_b.jpg)
Figure 2. Overall survival from start of palliative capecitabine or XELOX therapy for advanced colorectal cancer according to age < 70 and ≥70 years.
![Figure 2. Overall survival from start of palliative capecitabine or XELOX therapy for advanced colorectal cancer according to age < 70 and ≥70 years.](/cms/asset/e58a3e53-c36d-4dd0-81c6-a406e8e7de48/ionc_a_137504_f0002_b.jpg)
Figure 3. Progression free survival from start of palliative capecitabine therapy for advanced colorectal cancer according to age < 75 and ≥75 years.
![Figure 3. Progression free survival from start of palliative capecitabine therapy for advanced colorectal cancer according to age < 75 and ≥75 years.](/cms/asset/454daea9-f8ef-489f-9369-2104b682fef8/ionc_a_137504_f0003_b.jpg)
Figure 4. Overall survival from start of palliative capecitabine therapy for advanced colorectal cancer according to age < 75 and ≥75 years.
![Figure 4. Overall survival from start of palliative capecitabine therapy for advanced colorectal cancer according to age < 75 and ≥75 years.](/cms/asset/bcf21f5d-af26-4b25-ad70-c217d145b0f9/ionc_a_137504_f0004_b.jpg)
Table II. Response rates, tolerable dose as percent of standard dose and number of treatment courses according to age groups.
Table III. Baseline and worst performance status and weight change during capecitabine based chemotherapy for advanced colorectal cancer according to age groups
Table IV. Worst CTC grade toxicity during capecitabine based chemotherapy of advanced colorectal cancer according to age of patients.
Table V. Summary of studies comparing efficacy and toxicity of capecitabine based chemotherapy for advanced colorectal cancer according to age.